🔎 Trials Near Me

Gara Jalqabaatti › Saree Oljoo › Kentucky › Louisville

Qorannoo klinikaalii Saree Oljoo Louisville, KY keessatti

Qorannoo 11 Saree Oljoo f Louisville fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • University Medical Center, Inc. DBA University of Louisville Hospital/James Graham Brown Cancer Center, Louisville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07173751

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Namoota walitti qabaa jiraSadarkaa 3
  • UofL Health Brown Cancer Center, Louisville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06492616

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Louisville
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07647328

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • University of Louisville Hospital, Louisville
  • Baptist Health Louisville, Louisville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06790693

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Namoota walitti qabaa jiraSadarkaa 3
  • Baptist Health Louisville, Louisville
  • Baptist Health Floyd, New Albany · Miili 4 fagaatti
Umuriin 18 hanga 60 · Dubartoota · Haaromfame 02-Ful-2026 · NCT05879926

E-Mindfulness Approaches for Living After Breast Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Baptist Health Floyd, New Albany · Miili 4 fagaatti
Umuriin 18 hanga 50 · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT06748222

EXoPERT EMERALD Clinical Study

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • KCTL, Louisville
Umuriin 45 fi ol · Saalaa hunda · Haaromfame 01-Ado-2026 · NCT07186296

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Namoota walitti qabaa jiraSadarkaa 3
  • Norton Cancer Institute, Louisville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT05696626

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Baptist Floyd, New Albany · Miili 4 fagaatti
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT05366881

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Norton Cancer Institute - Downtown, Louisville
  • Baptist Health Louisville, Louisville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT06401421

Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • James Graham Brown Cancer Center, Louisville
Umuriin 18 fi ol · Dubartoota · Haaromfame 20-Gur-2025 · NCT04990921

Qorannoo Saree Oljoo magaalota biroo keessatti

Qorannoo biroo Louisville keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.